Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Titel:
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Auteur:
Heier, Jeffrey S Khanani, Arshad M Quezada Ruiz, Carlos Basu, Karen Ferrone, Philip J Brittain, Christopher Figueroa, Marta S Lin, Hugh Holz, Frank G Patel, Vaibhavi Lai, Timothy Y Y Silverman, David Regillo, Carl Swaminathan, Balakumar Viola, Francesco Cheung, Chui Ming Gemmy Wong, Tien Y